Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Revenue projections:

Revenue projections for ABBOTINDIA
Revenue projections for ABBOTINDIA

With ABBOTINDIA's revenues forecasted to be lower than last year's, investors are expected to be cautious. A decline in revenue typically harms the company's bottom line, reducing profitability and making investors less confident about the company's ability to sustain its financial health.

Financial Ratios:

currentRatio 3.386000
forwardPE 40.888454
debtToEquity 4.646000
earningsGrowth 0.279000
revenueGrowth 0.115000
grossMargins 0.426220
operatingMargins 0.255900
trailingEps 666.120000
forwardEps 0.000000

ABBOTINDIA's current ratio 3.386, suggesting the company has sufficient liquidity to service its short-term debt. With its cash reserves and current assets in good shape, ABBOTINDIA can comfortably meet its immediate liabilities, reflecting a healthy financial standing.
Abbott India Limited's positive earnings and revenue growth indicate that the company is on track to expand its business. This growth suggests a strong financial outlook, with increasing profits and sales positioning Abbott India Limited for continued success in the market.
Positive gross and operating margins for Abbott India Limited demonstrate the company's profitability. These margins reflect strong financial performance, with efficient operations contributing to the company's ability to generate consistent profits.

Price projections:

Price projections for ABBOTINDIA
Price projections for ABBOTINDIA

The price of Abbott India Limited has remained consistently close to the lower limit of projections. This ongoing pattern raises concerns about the stock's performance and may reflect market hesitance regarding the company's growth prospects.

Recommendation changes over time:

Recommendations trend for ABBOTINDIA
Recommendations trend for ABBOTINDIA


A recent buy bias from analysts toward ABBOTINDIA indicates strong confidence in the stock's future performance. This could encourage investors to park their money in ABBOTINDIA, viewing it as a stable and potentially rewarding investment opportunity with promising long-term growth prospects.